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according to the sociodemographic and clinical features, early disease onset
and PASI were found to be risk factors for the development of scalp psoria-
sis (p = 0.003, p < 0.001, respectively).
Conclusion: Scalp was the most commonly affected skin area. Clinical
severity and a younger age may increase the risk of the development of the
scalp involvement.
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Introduction: Psoriasis is a chronic inflammatory skin disease affecting
2–3% of the world population. Patients with psoriasis (Ps) have higher
prevalence of lipid disorders when compared to unaffected individuals.
These patients, especially those with severe and prolonged disease, have an
increased morbidity and mortality from cardiovascular events. Apolipopro-
tein E (ApoE), a protein involved in lipid metabolism, cholesterol and phos-
pholipid transport, has functionally relevant gene variants. It has been
described that the e4 allele may increase the risk to develop atherosclerosis,
and the e2 allele has been associated with hyperlipoproteinemia type III. An
increased risk of psoriasis among persons with these two alleles has also
been reported. Nevertheless, the role of ApoE in Psoriasis remains contro-
versial.
Objectives: The aim of this work was to investigate the relationship between
APOE-e2/e3/e4 variants and psoriasis in a Portuguese population.
Materials and Methods: A cohort of 178 unrelated (74 females, 104 males)
severe psoriatic patients [according to the Psoriasis Area and Severity Index
(PASI)] from Centro Hospitalar do Porto/Hospital de Santo Antonio and
285 ethnically-matched healthy controls were studied. Genotyping of APOE
was performed using a Polymerase chain reaction restriction fragment–
length polymorphism (PCR-RFLP) assay.
Results: The frequency of the e4 allele was significantly higher in patients
than in controls [(11.5% vs. 7.6%), p = 0.044, OR=1.57 (1.01–2.45)].
Conclusion: The ApoE e4 isoform could be a risk factor for psoriatic disease
in this population. Our result is in agreement with previous studies in a
Spanish population that associated the e4 isoform with severe psoriasis.
These results support the hypothesis that ApoE has a modulatory role in
inflammatory conditions.
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Introduction: The relations of infections to psoriatic disease are manifold.
Infections may either exacerbate the skin disease or may be predisposed by
immunomodulatory treatment. Accordingly, appropriate vaccinations are
advised for patients either before initiating disease or during treatment
course.
Objectives: To determine the state of vaccinations in psoriatic patients and
their consequences on disease course.
Materials and Methods: Four hundred and one patients with psoriasis were
contacted with a written questionaire asking for individual vaccinations,
their timely application and consequences on the course of psoriatic dis-
ease.
Results: Hundred and seventy one questionaires (42.2%) were returned with
very heterogenous states of recommended vaccinations like tetanus, diphthe-
ria and poliomyelitis. In many cases vaccination courses had not been applied
properly or were much outdated and needed booster injections. 45 patients
were vaccinated against classical influenca, 11 against swine flue. Among the
latter, one patient reported a relapse of psoriasis, one a deterioration, nine no
alterations at all. Among the other vaccinations (rubella, hepatitis B, typhoid)
eight patients reported either deterioration or relapse of their disease.
Conclusion: The state of vaccinations among randomly selected psoriasis
patients is very heterogenous and low-level with regard to appropriate pro-
tection against individual infections. The state of vaccinations should regu-
larly be chequed within relevant documents when available. Necessary and
recommended vaccinations should be applied before initiating any systemic
immunomodulatory treatment as well as appropriately be boostered during
further disease course.
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Introduction: Psoriasis is a frequent dermatosis, its prevalence is estimated
between 2 and 3%. We present here results of treatment and care for mili-
taries in Military Hospital of Tunis.
Objectives: We conducted a retrospective study on 69 cases of psoriasis col-
lected and hospitalized between 2008 and 2012. We included patients with
all type of psoriasis.
Materials and Methods: During the study period, 1633 cases were hospital-
ized and 69 militaries suffered from psoriasis (4.2%).The patients’ ages ran-
ged from 19 to 46 years, the mean age was 28.7 years old with clear male
predominance (64 men, 5 women). Patients had: plaque psoriasis (n = 63,
54.8%), Guttate psoriasis (n = 16, 14.7%) pustular psoriasis (n = 14,
12.8%), palmoplantar keratoderma psoriasis (n = 8, 7.3%), erythrodermic
psoriasis (n = 6, 5.5%) and inverse psoriasis (n = 2, 1.8%). Mean of the
extent psoriasis lesions was 67.2%. Local treatment with topical corticoster-
oids or a Vitamin D derivative alone or associated with systemic treatment
was recommended in respectively 77.6 and 9.2% of cases. The administra-
tion of general treated relied on methotrexate was required in 32.3%of
cases, UVB therapy in 36.2% of cases, systemic retinoid in 11.6% of cases.
Progression was usually good and it was in 85.5% of cases. Among the 69
soldiers suffering from psoriasis, five militaries (5.4%) were hospitalized to
determine the military service capacity. four of them were not fit for mili-
tary service.
Results: Psoriasis is a common, noticeable, inflammatory lifelong chronic
skin disease that can have a real impact in everyday life. Even if it’s benign
its treatment is binding especially the topical ones.In addition to the physi-
cal impact, psoriasis significantly affects mental and emotional functioning.
Our therapeutic managementis to hospitalize usually these militaries, isolate
them from stress conditions and try to treat them by topical or systemic
treatment (UVB, Methotrexate, systemic retinoid) even if their psoriasis is
moderate or not very extended. Psoriasis, its complications, and its thera-
pies can interfere with concentration, mission accomplishment and compli-
ance with safety equipment use and may have a specific and significant
impact that cannot allow psoriatic militaries to fit their service. Therefore,
psoriasis is a dermatological disease that should be taken seriously in mili-
taries compared to other people.
Conclusion: Care of psoriasis among militaries can differ from other psori-
atic patients by its real impact on their military service.
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